Britain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company Eli Lilly, the UK government has revealed. Eli Lilly's Mounjaro weight loss drug, like Wegovy, is injected. bcp/ajb/st

Orforglipron, a once-daily tablet produced by the same manufacturers as Mounjaro, has been given the green light by British health officials.

Storbritannien er det første europæiske land til at godkende selskabet Eli Lillys vægttabspille.

The UK has become the first country in Europe to authorise orforglipron, known as Foundayo

Britain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the UK. Foundayo will launch privately…